Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ryan A. Bragg is active.

Publication


Featured researches published by Ryan A. Bragg.


Organic Letters | 2010

Isothiourea-Mediated Stereoselective C-Acylation of Silyl Ketene Acetals

Philip A. Woods; Louis C. Morrill; Tomas Lebl; Alexandra M. Z. Slawin; Ryan A. Bragg; Andrew D. Smith

Isothiourea DHPB promotes the diastereoselective C-acylation of silyl ketene acetals with anhydrides or benzoyl fluoride, giving 3-acyl-3-aryl or 3-acyl-3-alkylfuranones in excellent yields and stereoselectivities (up to 99:1 dr).


Chemistry: A European Journal | 2011

Isothiourea-catalysed asymmetric C-acylation of silyl ketene acetals

Philip A. Woods; Louis C. Morrill; Ryan A. Bragg; Andrew D. Smith

Screening of a range of chiral isothioureas and acyl donors to promote the asymmetric C-acylation of silyl ketene acetals indicates that C(2)-aryl-dihydropyrimidobenzothiazole-derived isothioureas and propionic anhydride give optimal reactivity and enantioselectivity in this process. Under optimised conditions 3-acyl-3-aryl or 3-acyl-3-alkylfuranones are prepared in good yields and moderate to excellent enantioselectivities (up to 98% ee; ee=enantiomeric excess).


Bioorganic & Medicinal Chemistry Letters | 2015

Isotope chemistry; a useful tool in the drug discovery arsenal.

Charles S. Elmore; Ryan A. Bragg

As Medicinal Chemists are responsible for the synthesis and optimization of compounds, they often provide intermediates for use by isotope chemistry. Nevertheless, there is generally an incomplete understanding of the critical factors involved in the labeling of compounds. The remit of an Isotope Chemistry group varies from company to company, but often includes the synthesis of compounds labeled with radioisotopes, especially H-3 and C-14 and occasionally I-125, and stable isotopes, especially H-2, C-13, and N-15. Often the remit will also include the synthesis of drug metabolites. The methods used to prepare radiolabeled compounds by Isotope Chemists have been reviewed relatively recently. However, the organization and utilization of Isotope Chemistry has not been discussed recently and will be reviewed herein.


Chemistry: A European Journal | 2012

Isothiourea-Mediated Asymmetric O- to C-Carboxyl Transfer of Oxazolyl Carbonates: Structure–Selectivity Profiles and Mechanistic Studies

Caroline Joannesse; Craig P. Johnston; Louis C. Morrill; Philip A. Woods; Madeleine Kieffer; Tobias A. Nigst; Herbert Mayr; Tomas Lebl; Douglas Philp; Ryan A. Bragg; Andrew D. Smith

The structural motif within a series of tetrahydropyrimidine-based isothioureas necessary for generating high asymmetric induction in the asymmetric Steglich rearrangement of oxazolyl carbonates is fully explored, with crossover and dynamic (19)F NMR experiments used to develop a mechanistic understanding of this transformation.


Journal of Labelled Compounds and Radiopharmaceuticals | 2016

The synthesis of tritium, carbon-14 and stable isotope labelled selective estrogen receptor degraders.

Ryan A. Bragg; Nick Bushby; Cecilia Ericsson; Lee P. Kingston; Hailong Ji; Charles S. Elmore

As part of a Medicinal Chemistry program aimed at developing an orally bioavailable selective estrogen receptor degrader, a number of tritium, carbon-14, and stable isotope labelled (E)-3-[4-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl]prop-2-enoic acids were required. This paper discusses 5 synthetic approaches to this compound class.


Journal of Labelled Compounds and Radiopharmaceuticals | 2017

The synthesis of a tritium, carbon‐14, and stable isotope‐labeled cathepsin C inhibitors

Paul H. Allen; Ryan A. Bragg; Moya Caffrey; Cecilia Ericsson; Michael J. Hickey; Lee P. Kingston; Charles S. Elmore

As part of a medicinal chemistry program aimed at developing a highly potent and selective cathepsin C inhibitor, tritium, carbon-14, and stable isotope-labeled materials were required. The synthesis of tritium-labeled methanesulfonate 5 was achieved via catalytic tritiolysis of a chloro precursor, albeit at a low radiochemical purity of 67%. Tritium-labeled AZD5248 was prepared via a 3-stage synthesis, utilizing amide-directed hydrogen isotope exchange. Carbon-14 and stable isotope-labeled AZD5248 were successfully prepared through modifications of the medicinal chemistry synthetic route, enabling the use of available labeled intermediates.


Journal of Labelled Compounds and Radiopharmaceuticals | 2018

New trends and applications in carboxylation for isotope chemistry

Ryan A. Bragg; Malvika Sardana; Markus Artelsmair; Charles S. Elmore

Carboxylations are an important method for the incorporation of isotopically labeled 14CO2 into molecules. This manuscript will review labeled carboxylations since 2010 and will present a perspective on the potential of recent unlabeled methodology for labeled carboxylations. The perspective portion of the manuscript is broken into 3 major sections based on product type, arylcarboxylic acids, benzylcarboxylic acids, and alkyl carboxylic acids, and each of those sections is further subdivided by substrate.


Journal of Labelled Compounds and Radiopharmaceuticals | 2017

Isotope Labelling by Reduction of Nitriles: Application to the Synthesis of Isotopologues of Tolmetin and Celecoxib

Kate Ellis‐Sawyer; Ryan A. Bragg; Nick Bushby; Charles S. Elmore; Michael J. Hickey

The aryl methyl group is found in many drug-like compounds, but there are limited ways of preparing compounds with an isotope label in this methyl position. The process of cyanation of an aryl halide followed by complete reduction of the nitrile to a methyl group was investigated as a route for preparing stable and radiolabelled isotopologues of drug-like compounds. Using this methodology, carbon-13, deuterium, carbon-14, and tritium labelled isotopologues of the nonsteroidal anti-inflammatory drug tolmetin were produced, as well as carbon-13, deuterium, and carbon-14 labelled isotopologues of another nonsteroidal anti-inflammatory drug, celecoxib. The radiolabelled compounds were produced at high specific activity and the stable isotope labelled compounds with high incorporation making them suitable for use as internal standards in mass spectrometry assays. This approach provides a common synthetic route to multiple isotopologues of compounds using inexpensive and readily available labelled starting materials.


Organic and Biomolecular Chemistry | 2011

Structure-enantioselectivity effects in 3,4-dihydropyrimido[2,1-b]benzothiazole-based isothioureas as enantioselective acylation catalysts

Dorine Belmessieri; Caroline Joannesse; Philip A. Woods; Callum MacGregor; Caroline Jones; Craig D. Campbell; Craig P. Johnston; Nicolas Duguet; Carmen Concellón; Ryan A. Bragg; Andrew D. Smith


Bioorganic & Medicinal Chemistry Letters | 2003

Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the methylene spacer and the P1' side chain.

Stephen J. Davies; R.Paul Beckett; Ryan A. Bragg; John M. Clements; Sheila Doel; Christine Grew; Steven B. Launchbury; Gemma M. Perkins; Lisa M. Pratt; Helen Katherine Smith; Zoe Marie Spavold; S.Wayne Thomas; Richard S. Todd; Mark Whittaker

Collaboration


Dive into the Ryan A. Bragg's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge